MK-8876

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8876, covering 2016-02-04 to 2016-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003) [Phase 1]

See pricing